MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,771,441
+120.2%
95,547
+31.3%
0.00%
Q2 2023$804,560
-19.5%
72,745
-2.3%
0.00%
Q1 2023$999,984
-49.3%
74,459
-53.3%
0.00%
-100.0%
Q4 2022$1,972,557
-9.4%
159,463
+2.2%
0.00%0.0%
Q3 2022$2,177,000
+0.1%
156,087
-0.9%
0.00%0.0%
Q2 2022$2,175,000
-14.7%
157,510
+0.5%
0.00%0.0%
Q1 2022$2,550,000
+0.9%
156,715
+1.0%
0.00%0.0%
Q4 2021$2,527,000
+226.5%
155,108
+197.5%
0.00%
Q3 2021$774,000
-88.3%
52,143
+1.1%
0.00%
-100.0%
Q1 2016$6,628,000
-31.3%
51,588
-20.2%
0.00%
-40.0%
Q4 2015$9,654,000
-10.6%
64,644
-0.7%
0.01%
-16.7%
Q3 2015$10,796,000
-99.9%
65,093
-18.2%
0.01%
-40.0%
Q2 2015$19,209,503,000
-22.8%
79,582
-9.8%
0.01%
-23.1%
Q1 2015$24,873,600,000
+84.9%
88,198
+2.3%
0.01%
+85.7%
Q4 2014$13,449,072,000
+826.8%
86,212
+1859.4%
0.01%
+600.0%
Q1 2014$1,451,076,0004,4000.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders